These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

327 related articles for article (PubMed ID: 22960774)

  • 1. Effects of fluoxetine on CRF and CRF1 expression in rats exposed to the learned helplessness paradigm.
    Fernández Macedo GV; Cladouchos ML; Sifonios L; Cassanelli PM; Wikinski S
    Psychopharmacology (Berl); 2013 Feb; 225(3):647-59. PubMed ID: 22960774
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SSRI or CRF antagonism partially ameliorate depressive-like behavior after adolescent social defeat.
    Bourke CH; Glasper ER; Neigh GN
    Behav Brain Res; 2014 Aug; 270():295-9. PubMed ID: 24867331
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of the CRF
    Wróbel A; Serefko A; Szopa A; Rojek K; Poleszak E; Skalicka-Woźniak K; Dudka J
    Naunyn Schmiedebergs Arch Pharmacol; 2017 Aug; 390(8):769-774. PubMed ID: 28429110
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fluoxetine attenuates stress-induced depressive-like behavior through modulation of hippocampal GAP43 and neurogenesis in male rats.
    Zavvari F; Nahavandi A; Goudarzi M
    J Chem Neuroanat; 2020 Jan; 103():101711. PubMed ID: 31705954
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of the amygdala in antidepressant effects on hippocampal cell proliferation and survival and on depression-like behavior in the rat.
    Castro JE; Varea E; Márquez C; Cordero MI; Poirier G; Sandi C
    PLoS One; 2010 Jan; 5(1):e8618. PubMed ID: 20062812
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SN003, a CRF
    Wróbel A; Doboszewska U; Rechberger E; Wlaź P; Rechberger T
    Eur J Pharmacol; 2017 Oct; 812():216-224. PubMed ID: 28705713
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Escitalopram alters gene expression and HPA axis reactivity in rats following chronic overexpression of corticotropin-releasing factor from the central amygdala.
    Flandreau EI; Bourke CH; Ressler KJ; Vale WW; Nemeroff CB; Owens MJ
    Psychoneuroendocrinology; 2013 Aug; 38(8):1349-61. PubMed ID: 23267723
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of fluoxetine on depression-induced changes in the expression of vasoactive intestinal polypeptide and corticotrophin releasing factor in rat duodenum.
    Huang YL; Yu JP; Wang GH; Chen ZH; Wang Q; Xiao L
    World J Gastroenterol; 2007 Dec; 13(45):6060-5. PubMed ID: 18023100
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The CRF1 receptor mediates the excitatory actions of corticotropin releasing factor (CRF) in the developing rat brain: in vivo evidence using a novel, selective, non-peptide CRF receptor antagonist.
    Baram TZ; Chalmers DT; Chen C; Koutsoukos Y; De Souza EB
    Brain Res; 1997 Oct; 770(1-2):89-95. PubMed ID: 9372207
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activation of CRF/CRFR1 signaling in the basolateral nucleus of the amygdala contributes to chronic forced swim-induced depressive-like behaviors in rats.
    Chen L; Li S; Cai J; Wei TJ; Liu LY; Zhao HY; Liu BH; Jing HB; Jin ZR; Liu M; Wan Y; Xing GG
    Behav Brain Res; 2018 Feb; 338():134-142. PubMed ID: 29080675
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CRF-CRF1 receptor system in the central and basolateral nuclei of the amygdala differentially mediates excessive eating of palatable food.
    Iemolo A; Blasio A; St Cyr SA; Jiang F; Rice KC; Sabino V; Cottone P
    Neuropsychopharmacology; 2013 Nov; 38(12):2456-66. PubMed ID: 23748225
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fluoxetine induces the transcription of genes encoding c-fos, corticotropin-releasing factor and its type 1 receptor in rat brain.
    Torres G; Horowitz JM; Laflamme N; Rivest S
    Neuroscience; 1998 Nov; 87(2):463-77. PubMed ID: 9740405
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adolescence fluoxetine increases serotonergic activity in the raphe-hippocampus axis and improves depression-like behaviors in female rats that experienced neonatal maternal separation.
    Yoo SB; Kim BT; Kim JY; Ryu V; Kang DW; Lee JH; Jahng JW
    Psychoneuroendocrinology; 2013 Jun; 38(6):777-88. PubMed ID: 23010142
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Don't stress about CRF: assessing the translational failures of CRF
    Spierling SR; Zorrilla EP
    Psychopharmacology (Berl); 2017 May; 234(9-10):1467-1481. PubMed ID: 28265716
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Suppression of the MEK/ERK signaling pathway reverses depression-like behaviors of CRF2-deficient mice.
    Todorovic C; Sherrin T; Pitts M; Hippel C; Rayner M; Spiess J
    Neuropsychopharmacology; 2009 May; 34(6):1416-26. PubMed ID: 18843268
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sex differences in CRF1, CRF, and CRFBP expression in C57BL/6J mouse brain across the lifespan and in response to acute stress.
    Locci A; Yan Y; Rodriguez G; Dong H
    J Neurochem; 2021 Aug; 158(4):943-959. PubMed ID: 32813270
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulation of corticotropin-releasing factor type 1 (CRF1) receptor messenger ribonucleic acid in the paraventricular nucleus of rat hypothalamus by exogenous CRF.
    Mansi JA; Rivest S; Drolet G
    Endocrinology; 1996 Nov; 137(11):4619-29. PubMed ID: 8895325
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Corticotropin-releasing hormone (CRH) downregulates the function of its receptor (CRF1) and induces CRF1 expression in hippocampal and cortical regions of the immature rat brain.
    Brunson KL; Grigoriadis DE; Lorang MT; Baram TZ
    Exp Neurol; 2002 Jul; 176(1):75-86. PubMed ID: 12093084
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reversal of learned helplessness by selective serotonin reuptake inhibitors in rats is not dependent on 5-HT availability.
    Zazpe A; Artaiz I; Labeaga L; Lucero ML; Orjales A
    Neuropharmacology; 2007 Mar; 52(3):975-84. PubMed ID: 17141811
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anxiolytic- and antidepressant-like profile of a new CRF1 receptor antagonist, R278995/CRA0450.
    Chaki S; Nakazato A; Kennis L; Nakamura M; Mackie C; Sugiura M; Vinken P; Ashton D; Langlois X; Steckler T
    Eur J Pharmacol; 2004 Feb; 485(1-3):145-58. PubMed ID: 14757135
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.